Rapid plasma reagin test is a serological test used to screen you for syphilis, a sexually transmitted infection caused by spirochete bacterium treponema pallidum. 
This report contains market size and forecasts of Rapid Plasma Reagin Test in Global, including the following market information:
Global Rapid Plasma Reagin Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rapid Plasma Reagin Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rapid Plasma Reagin Test include Cardinal Health, Thermo Fisher Scientific, Abbott, Siemens, Sekisui Chemical, Immunostics, Danaher, Roche and Novacyt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rapid Plasma Reagin Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rapid Plasma Reagin Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rapid Plasma Reagin Test Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Global Rapid Plasma Reagin Test Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rapid Plasma Reagin Test Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialty Clinic
Diagnostics Laboratory
Others
Global Rapid Plasma Reagin Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rapid Plasma Reagin Test Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Plasma Reagin Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rapid Plasma Reagin Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cardinal Health
Thermo Fisher Scientific
Abbott
Siemens
Sekisui Chemical
Immunostics
Danaher
Roche
Novacyt
Meridian Bioscience
Arlington Scientific
Bio-Rad Laboratories